My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.4476 -0.0124 (-2.70%)

Streaming Delayed Price Updated: 3:34 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sangamo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 10, 2025

Via Benzinga

This CarMax Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

November 07, 2025

Via Benzinga

Sangamo (SGMO) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Sangamo (SGMO) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Sangamo Therapeutics Inc (NASDAQ:SGMO) Stock Plummets 22% After Q3 Earnings Miss ↗

November 06, 2025

Sangamo stock plunges 22% after Q3 earnings miss, with revenue of $0.58M falling far short of the $35.09M analyst estimate.

Via Chartmill

Topics Earnings

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

November 06, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

Sangamo Therapeutics Inc (NASDAQ:SGMO) Reports Q2 2025 Earnings: Revenue Misses but Narrower-Than-Expected Loss ↗

August 07, 2025

Sangamo Therapeutics (SGMO) reported Q2 2025 results with revenue missing estimates at $18.31M but a narrower loss of $0.08/share. Shares fell 9% post-earnings despite positive Fabry disease trial...

Via Chartmill

Tuesday's pre-market session: top gainers and losers ↗

June 24, 2025

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

June 24, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

These stocks are moving in today's session ↗

May 13, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Tuesday's session: top gainers and losers ↗

May 13, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 13, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

May 13, 2025

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Which stocks are moving before the opening bell on Tuesday? ↗

May 13, 2025

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 13, 2025

Via Benzinga

US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert ↗

May 13, 2025

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.

Via Benzinga

Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

May 13, 2025

Via Benzinga

Which stocks are moving after the closing bell on Monday? ↗

May 12, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results

May 12, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering

May 12, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 12, 2025

Via Benzinga

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day

May 12, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

May 06, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

May 06, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

April 28, 2025

From Sangamo Therapeutics, Inc.

Via Business Wire

Friday's pre-market session: top gainers and losers ↗

April 04, 2025

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 04, 2025

Via Benzinga

US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert ↗

April 04, 2025

U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump's tariffs.

Via Benzinga

Topics Government

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.